MYO - Myomo, Inc.
| Previous Close | 3.74 |
| Open | 3.75 |
| Bid | 3.75 x 100 |
| Ask | 4.29 x 300 |
| Day's Range | 3.73 - 3.89 |
| 52 Week Range | 2.07 - 23.20 |
| Volume | 304,147 |
| Avg. Volume | 680,661 |
| Market Cap | 47.587M |
| Beta | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.93 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.50 |
- GlobeNewswire•23 days ago
Recent Analysis Shows Myomo, Shiloh Industries, Regal Beloit, Teledyne Technologies, Envestnet, and Independent Bank Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, April 04, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- ACCESSWIRE•last month
SeeThruEquity Issues Update on Myomo, Inc.
NEW YORK, NY / ACCESSWIRE / March 22, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued ...
- Business Wire•last month
UPDATE - Myomo Reports Fourth Quarter and Year End 2017 Results
Myomo, Inc. , a commercial stage medical robotics company, today announced that it is updating its previous release that was made on March 7, 2018 to incorporate certain disclosures that are required under the NYSE AMERICAN Company Guide Sections 401 and 610 .
- Business Wire•2 months ago
Myomo Welcomes 13 New Center of Excellence Locations
Myomo, Inc. , a commercial stage medical robotics company, today announced the addition of three new orthotics and prosthetics practices and 13 new locations to its MyoPro Center of Excellence program, which recognizes top O&P practices that support the MyoPro line of powered orthoses.
- Business Wire•2 months ago
Myomo Announces Participation at Upcoming Investor and Partnering Conferences
Myomo, Inc. , a commercial stage medical robotics company, today announced that Chairman and Chief Executive Officer Paul R. Gudonis will be participating at two upcoming investor, partnering and collaboration conferences.
- Business Wire•2 months ago
Myomo, Inc. Issues March 2018 Shareholder Letter
Myomo, Inc. , a commercial stage medical robotics company, today issued a letter to shareholders to give an update on fourth quarter 2017 and ongoing MyoPro® commercial activities.
- Business Wire•2 months ago
Myomo Reports Fourth Quarter and Year End 2017 Results
Myomo, Inc. , a commercial stage medical robotics company, today reports its financial results for the fourth quarter and year end December 31, 2017.
- Business Wire•2 months ago
Myomo to Present at the 30th Annual ROTH Conference
Myomo, Inc. , a commercial stage medical robotics company, today announced that it will be presenting at the 30th Annual ROTH Conference in Dana Point, CA on Monday, March 12th at 9:00 AM PT, Blue - Salon 2.
- Business Wire•2 months ago
Myomo to Report Fourth Quarter and Year End 2017 Results on March 7, 2018
Myomo, Inc. , a commercial stage medical robotics company, today announced that it will release its financial results for the fourth quarter and year end December 31, 2017 results on Wednesday, March 7, 2018, after the US markets close.
- Business Wire•2 months ago
Myomo and GRE to Conduct Screening Days in Ohio and Detroit
Myomo, Inc. , a commercial stage medical robotics company, and Geauga Rehabilitation Engineering have announced a series of free screening days to be held at the offices of GRE and its local partners near Cleveland, Detroit, Columbus and Cincinnati.
- PR Newswire•3 months ago
Johnson Fistel, Announces Investigations of ADOMANI, Inc., ShiftPixy, Inc., Arcimoto, Inc., Myomo, Inc., FAT Brands Inc., Level Brands, Inc. and Chicken Soup for the Soul Entertainment, Inc.; Investors with Losses Encouraged to Contact Firm
SAN DIEGO , Feb. 6, 2018 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against ADOMANI, Inc., ShiftPixy, Inc., Arcimoto, Inc., Myomo, Inc., FAT Brands ...
- GlobeNewswire•3 months ago
New Research: Key Drivers of Growth for Tallgrass Energy GP, LP, Lithia Motors, Akcea Therapeutics, Meridian Bioscience, Myomo, and Liberty Media — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Feb. 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tallgrass ...
- TheStreet.com•3 months ago
8 Stocks That Are Ready to Change Direction
These names are displaying bullish and bearish reversal patters over the last week.
- Business Wire•3 months ago
Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center
Myomo, Inc. , a commercial stage medical robotics company, and the Massachusetts Life Sciences Center today celebrated Myomo’s repayment of a $750,000 accelerator loan provided by the MLSC in 2011.
- Business Wire•3 months ago
Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference
Myomo, Inc. , a commercial stage medical robotics company, today announced that it will be presenting at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 29th at 11:00 AM EST - Studio 4.
- Forbes•4 months ago
Muscle Maker Grill Raising $19 Million Via Regulation A+ IPO To Accelerate Acquisitions
The MMG offering has no minimum (an advantage of Reg A+over the traditional S-1 IPO) and a maximum of $19.95 million dollars at a pre-money valuation of $51 mill. The company's market is forecast to grow to $64 billion by 2019, representing a Compound Annual Growth Rate of 10.2%.
- Business Wire•5 months ago
Myomo, Inc. Announces Full Exercise of Underwriter’s Over-Allotment Option in Follow-On Public Offering
Myomo, Inc. , a commercial stage medical robotics company, today announced that Roth Capital Partners, the underwriter of Myomo’s follow-on offering, exercised in full its option to purchase 626,250 shares of common stock and accompanying warrants to purchase 626,250 shares of common stock, at a combined price to the public of $2.40 per share of common stock and accompanying warrant, for gross proceeds ...
- Business Wire•5 months ago
Myomo, Inc. Announces Pricing of Public Offering
Myomo, Inc. , a commercial stage medical robotics company, today announced that it has priced an underwritten public offering of 4,175,000 shares of its common stock and accompanying warrants to purchase 4,175,000 shares of common stock.
- Simply Wall St.•5 months ago
How Financially Strong Is Myomo Inc (MYO)?
Investors are always looking for growth in small-cap stocks like Myomo Inc (AMEX:MYO), with a market cap of USD $23.06M. However, an important fact which most ignore is: how financiallyRead More...
- Business Wire•5 months ago
Myomo Expands MyoPro® Centers of Excellence Program
Myomo, Inc. , a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics locations to its Center of Excellence program, which recognizes top O&P practices that support the MyoPro line of powered orthoses.
- Business Wire•5 months ago
Myomo, Inc. to Present at the 10th Annual LD Micro Main Event
Myomo, Inc. , a commercial stage medical robotics company, today announced that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5th at 9:30 AM PST / 12:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
- Forbes•5 months ago
Level Brands' IPO Lists On The NYSE; How And Why They Switched To Regulation A+
Today Level Brands Inc became the seventh Regulation A+ IPO to complete and the second to list and trade on the NYSE American Exchange. The company raised its maximum of $12 million by selling 2 million shares at $6 each at a pre-money valuation of $35 million. The ticker is NYSE: LEVB
- Business Wire•5 months ago
Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering
Myomo, Inc. , a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase common stock.
- Business Wire•6 months ago
Myomo, Inc. Issues November 2017 Shareholder Letter
Myomo, Inc. , a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities.
- Business Wire•6 months ago
Myomo Enters Canadian Market
Myomo, Inc. , a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada.
